交易中 11-18 10:43:29 美东时间
+1.425
+3.52%
中国上海、美国马萨诸塞州剑桥和荷兰鹿特丹2026年11月18日 /美通社/ -- 和铂医药(股票代码:02142.HK),一家专注于免疫性疾病、肿瘤及其他领域创...
今天 08:05
Spruce Biosciences (NASDAQ:SPRB) reported quarterly losses of $(8.51) per share. This is a 41.63 percent increase over losses of $(14.58) per share from the same period last year.
11-09 22:30
Transaction Expected to Create Two Independent, Publicly Traded Companies with Distinct Strategic Priorities, Separate Capital Structures and Dedicated TeamsUp to $50 Million Committed to Adrenyx from Leading
11-09 20:14
Harbour BioMed exercises its warrant to buy Spruce Biosciences shares, raising its stake to about 3.8% as the companies work together on the SPR202 drug program.
01-21 20:24